Skip to content

The CPR, Pre-hospital ECPR and Early Reperfusion Study: A Target Trial Emulation

The CPR, Pre-hospital ECPR and Early Reperfusion Study: A Target Trial Emulation (CHEER4TTE)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07679737
Acronym
CHEER4TTE
Enrollment
250
Registered
2026-07-01
Start date
2025-01-01
Completion date
2026-10-01
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Cardiopulmonary Resuscitation, Out of Hospital Cardiac Arrest

Keywords

ECMO, ECPR, Extracorporeal membrane oxygenation, ECMO CPR, at the scene, scene based, OHCA

Brief summary

CHEER4TTE is a target trial emulation, designed to simulate a randomised controlled trial by utilising data from pre-existing data sources. The aim is to determine whether prehospital ECPR for refractory out-of-hospital cardiac arrest improves the rate of survival to hospital discharge when compared to conventional cardiac arrest care.

Interventions

The Intervention being evaluated is the initiation of extracorporeal cardiopulmonary resuscitation (ECPR) at the scene, in addition to conventional cardiac arrest care.

Sponsors

Australian and New Zealand Intensive Care Research Centre
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Witnessed cardiac arrest * Bystander CPR * Refractory cardiac arrest (failure to achieve sustained ROSC \>20 minutes) * Initial cardiac rhythm VF, VT or PEA * Within the hours of prehospital ECPR service operation

Exclusion criteria

* Initial cardiac rhythm asystole * ROSC with sustained recovery * Unable to reach the patient and commence cannulation within 45 minutes of onset of arrest * Evidence of/suspected end-stage disease: * severe disability impairing activities of daily living * end-stage organ disease - cardiac, liver, lung, renal * other life-limiting diseases, e.g. malignancy, terminal illness * advance health care directive * Time periods of advanced public health restrictions in Victoria and NSW due to COVID-19

Design outcomes

Primary

MeasureTime frame
Survival to hospital dischargeFrom meeting full eligibility criteria until the date/time of death or hospital discharge, assessed up to 180 days

Secondary

MeasureTime frame
Low flow timetime from onset of arrest to time of ECPR flow, or time of death
ICU length of stayFrom the date/time of ICU admission until the date/time of ICU discharge/death, assessed up to 180 days
Mechanical ventilation daysFrom date/time of mechanical ventilation commencement until date/time of liberation from mechanical ventilation assessed up to 180 days
ECMO complicationsFrom the date/time of commencement of ECMO support until 1 week following the date/time of cessation of ECMO support
Rates of organ and tissue donation in non-survivorsIn the 48hours following date/time of death

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026